panel: cell and gene therapies for ophthalmologic diseases
Published 3 years ago • 212 plays • Length 53:56Download video MP4
Download video MP3
Similar videos
-
1:05:49
panel: cell and gene therapies for chronic conditions
-
54:19
panel: cell and gene therapy for neurological product indications
-
38:10
panel: emerging therapies for ophthalmologic disorders
-
49:16
panel: the state of investment in cell and gene therapy
-
23:40
expediting the development of cell and gene therapy
-
59:49
plenary session: gene therapy & gene-modified cell therapies
-
52:32
panel: when does investing in cell and gene therapy make business sense?
-
59:51
panel: next generation cell and gene therapy in oncology
-
1:11:29
panel: acceptance and uptake of cell and gene therapies: lessons learned and future focus
-
1:02:29
panel: safety and efficacy considerations for cell and gene therapies
-
2:40
the changing landscape of hospital-based cell and gene therapy manufacturing
-
51:10
panel: cell and gene therapy portfolio strategies
-
6:04
panel introduction: cell therapy for hematopoietic disorders and beyond
-
16:25
fda’s efforts to advance the development and approval of cellular and gene therapies
-
55:19
panel: large cap cell & gene therapy strategies
-
59:51
panel: what cell & gene therapy investors are looking for now
-
44:30
panel: gene therapy manufacturing
-
15:11
voyager therapeutics - company presentation
-
1:00:38
panel: personalizing cardiovascular therapies to address the underlying causes of disease